Literature DB >> 898244

Cerebral arterial smooth muscle contraction by thromboxane A2.

E F Ellis, A S Nies, J A Oates.   

Abstract

The contractile effects of thromboxane A2 (TxA2), a labile arachidonic acid metabolite, were studied in arterial smooth muscle strips. TxA2 was generated upon the addition of 255 nM prostaglandin cyclic endoperoxide H2 to human platelet particles in the muscle bath. Using the isometric contaction produced by 40 mM K+ in isotonic saline as the reference contraction, bovine middle cerebral artery strips contracted to 153 +/- 14% of the reference response while bovine coronary and porcine coronary, renal and common carotid strips contracted to 47 +/- 3, 26 +/- 5, 43 +/- 2 and 2 +/- 1% of reference, respectively. The cerebral artery response to the TxA2 generating system was as great as the maximum response to prostaglandin F2alpha and two times the maximum response to 5-hydroxytryptamine. Because TxA2 is formed by brain tissue and released from aggregating platelets, it may be important in the pathogenesis of spasm associated with injured brain tissue or pathologic changes leading to platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 898244     DOI: 10.1161/01.str.8.4.480

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability.

Authors:  M Zuccarello; T Sasaki; N F Kassell; M Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Up-regulation of thromboxane A₂ impairs cerebrovascular eNOS function in aging atherosclerotic mice.

Authors:  Annick Drouin; Nada Farhat; Virginie Bolduc; Nathalie Thorin-Trescases; Marc-Antoine Gillis; Louis Villeneuve; Albert Nguyen; Eric Thorin
Journal:  Pflugers Arch       Date:  2011-05-27       Impact factor: 3.657

3.  Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors.

Authors:  Peter Toth; Bernadett Rozsa; Zsolt Springo; Tamas Doczi; Akos Koller
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-25       Impact factor: 6.200

4.  Blood-arterial wall barrier disruption to various sized tracers following subarachnoid haemorrhage.

Authors:  T Nakagomi; N F Kassell; H Johshita; R M Lehman; S Fujiwara; T Sasaki
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients.

Authors:  N Iwamoto; K Kobayashi; K Kosaka
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

6.  Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

Review 7.  Strokes, transient ischemic attacks and asymptomatic bruits.

Authors:  H I Machleder
Journal:  West J Med       Date:  1979-03

8.  Interference of levamisole with cerebral edema.

Authors:  A Casacó; D Carvajal
Journal:  Agents Actions       Date:  1990-08

9.  Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.

Authors:  Adam Jangula; Eric J Murphy
Journal:  Neurosci Lett       Date:  2013-07-19       Impact factor: 3.046

10.  Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy.

Authors:  K Yano; T Kuroda; Y Tanabe; H Yamada
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.